好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Randomized Double Blind Placebo Controlled Trial of Memantine 10 mg Twice a Day for Three Months as a Treatment for Cognitive Impairment in Multiple Sclerosis
MS and Related Diseases
(-)
002
Authors/Disclosures
Jesus Lovera, MD (LSUHSC-New Orleans) Dr. Lovera has nothing to disclose.
Charlene J. Ong, MD (Boston University) Dr. Ong has nothing to disclose.
Elliot M. Frohman, MD, FAAN Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date. Dr. Frohman has received publishing royalties from a publication relating to health care.
Theodore R. Brown, MD (MS Center At Evergreen) Dr. Brown has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astellas. The institution of Dr. Brown has received research support from Merck.
Daniel Bandari, MD (MS Center of California) No disclosure on file
Ruth H. Whitham, MD, FAAN No disclosure on file
No disclosure on file
Dennis N. Bourdette, MD, FAAN Dr. Bourdette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Magellan Health Care. Dr. Bourdette has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctor's Inc. Dr. Bourdette has stock in Authobahn Therapeutics. Dr. Bourdette has received intellectual property interests from a discovery or technology relating to health care.